Please see profiles on each of the Directors below:
Andrew Joy (Chairman)
Andrew Joy joined the Board in March 2012. He was one of the founding Partners of Cinven, a leading private equity firm investing in Europe and U.S. where he continues as a Senior Advisor. He is a Senior Advisor of Stonehage Fleming Group and Chairman of the investment committee of FPE Capital. private equity investment committee. Mr Joy has been Chairman & Director of numerous growing Companies over the past 30 years. He is former Chairman of the BVCA (British Venture Capital and Private Equity Associate) and Director of the EVCA.
Sven Borho joined the Board in March 2006 and is a founding Partner of OrbiMed, the Company’s Investment Manager. He is a senior member of the public equity team and is a portfolio manager for OrbiMed’s public equity and hedge funds. He started his career in 1991 when he joined OrbiMed’s predecessor firm as a Senior Analyst covering European pharmaceutical firms and biotechnology companies worldwide. He studied business administration at Bayreuth University in Germany and received a MSc (Econs.), Accounting and Finance, from the London School of Economics.
Steven Bates was appointed to the board on 8 July 2015 and is Chairman of the Management Engagement Committee. He is the Chairman of Vietnam Opportunities Fund, of Baring Emerging Europe plc and of F&C Capital and Income Investment Trust. Other directorships held by him include British Empire Trust plc and GuardCap Asset Management Ltd. He has a wealth of experience as an investment manager and sits on or is adviser to various committees in the wealth management and pension fund areas. Previously he was head of global emerging markets at JP Morgan Asset Management.
Professor Dame Kay Davies, CBE
Professor Dame Kay Davies CBE joined the Board in March 2012 and is Chairman of the Remuneration Committee. She is the Dr Lee’s Professor of Anatomy and Associate Head of the Medical Sciences Division at the University of Oxford and a fellow of Hertford College. She is also a Co-Director of the Oxford Neuromuscular Centre, Deputy Chairman of the Wellcome Trust and a member of the Scientific Advisory Board of UCB Pharma S. A.
As part of her role as Deputy Chairman of the Wellcome Trust she serves on the GRL Board (Sanger Institute) and the Genome England Board (NHS).
Lord Willetts joined the Board in November 2015. He is Executive Chairman of the Resolution Foundation and a Visiting Professor at King's College London. He is Governor of the Ditchley Foundation, a member of the Council of the Institute for Fiscal Studies and a Board member of the Francis Crick Institute and of the Biotech Industry Association. He was Minister for Universities and Science, attending Cabinet, from 2010-2014. He was the Member of Parliament for Havant from 1992-2015. Before that, Lord Willetts worked at HM Treasury and the Number 10 Policy Unit. He also served as Paymaster General in the last Conservative Government.
Julia Le Blan
Julia Le Blan joined the Board on 12 July 2016 and is Chairman of the Audit Committee. A Chartered Accountant, she has worked in the financial services industry for over 30 years. She was formerly a tax partner at Deloitte and sat for two terms on the AIC's technical committee. Julia is a non-executive director of F&C UK High Income Trust plc, Impax Environmental Markets plc, JP Morgan US Smaller Companies Investment Trust plc and Aberforth Smaller Companies Trust plc.
All Directors, with the exception of Sven Borho, are members of the Audit, Management Engagement, Nominations and Remuneration Committees.
Read about the anti-bribery and corruption policies here.